EPICYPHER, INC.

EPICYPHER, INC. specializes in advanced chemical manufacturing processes and precision formulation technologies, leveraging its expertise in organic synthesis, process scale-up, and quality systems compliant with federal regulatory standards. The company’s core capabilities center on the development and production of specialty chemicals, including active pharmaceutical ingredients, high-purity reagents, and custom-engineered compounds for mission-critical applications. Their technical proficiency includes reactor design optimization, chromatographic purification, analytical method validation, and GMP-aligned batch documentation, ensuring consistency and traceability in regulated environments. EPICYPHER distinguishes itself through agile process innovation and rigorous adherence to chemical safety and environmental control protocols, enabling rapid response to evolving government supply chain demands. Award history is not available to confirm specific agency engagements, so no definitive patterns of work with federal departments can be inferred. Similarly, without contract data, no agency-specific project types or relationship durations can be described. The company operates under NAICS 325411, which corresponds to the manufacturing of pharmaceutical and medicine products, indicating a focus on high-precision chemical synthesis for government and defense-related biomedical applications. This positions EPICYPHER within the life sciences and national security supply chain, serving as a niche provider of mission-critical chemical intermediates and formulations. As a small business structured as a 2L entity based in Durham, North Carolina, EPICYPHER maintains a focused operational footprint with no public certifications on record. Its geographic presence in a major biotech and research corridor enhances access to academic and federal laboratory partnerships, supporting its role as a specialized supplier in the federal chemical manufacturing ecosystem.